sodium (S)-2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide

Catalog No. :
ACQCDX031
CAS No. :
171440-19-0
Molecular Formula :
C18H20N3NaO3S
Molecular Weight :
381.43

IUPAC Name:sodium (S)-2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide

sodium (S)-2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namesodium (S)-2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide
IUPAC Namesodium (S)-2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide
Molecular FormulaC18H20N3NaO3S
Molecular Weight381.43
SMILESCOCCCOC1=C(C)C(C[S@](=O)C2=NC3=CC=CC=C3[N-]2)=NC=C1.[Na+]
InChI KeyKRCQSTCYZUOBHN-UQIIZPHYSA-N
SynonymRabeprazole SodiumDR | sodium;2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]benzimidazol-1-ide | AS-13338 | FT-0689461 | HMS3373B05 | 3-Ethyl-2-methyl-5-(morpholinomethyl)-6,7-dihydro-1H-indol-4(5H)-one hydrochloride | AKOS015895734 | DTXSI
CAS No.171440-19-0
PubChem CID14720269

Synthetic Route by SureRoute

1. ACQCDX031 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCNRK235 route compound structure diagram
    ACCNRK235117977-21-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQCDX031 route product structure diagram
    ACQCDX031171440-19-0
Inquiry

2. ACQCDX031 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCNRK235 route compound structure diagram
    ACCNRK235117977-21-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQCDX031 route product structure diagram
    ACQCDX031171440-19-0
Inquiry

Comments (0)